Search Results 391-400 of 19195 for hemoglobin

  1. A Study of Biomarkers for Human Heart Failure - Mayo Clinic

    Hemoglobin less than 10, active cancer, amyloidosis. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the ...

  2. Detection of Plasma DNA Methylation in Peripheral Blood from Patients with Hepatocellular Carcinoma - Mayo Clinic

    - Patient with significant anemia (hemoglobin [Hb] < 7g/dL) - Patient has known cancer outside of the liver 5 years prior to current blood collection (not ...

  3. Clinical trials - Oncology (Medical)

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  4. Neurology - Clinical trials

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  5. Coronary Artery Bypass Surgery Clinical Trials - Mayo Clinic Research

    The purpose of this study is to test if a reduction of hemoglobin leads to subclinical cardiac dysfunction in patients with known cardiovascular disease. .

  6. Testing Proton Craniospinal Radiation Therapy Versus The Usual Radiation Therapy For Leptomeningeal Metastasis, RADIATE-LM Trial - Mayo Clinic

    * Hemoglobin ≥ 8.0 g/dl (Note: The use of transfusion or other intervention to achieve hemoglobin [Hgb] ≥ 8.0 g/dl is acceptable) * Absolute neutrophil ...

  7. Neurology - Clinical trials

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  8. Publications - Lance A. Williams, III, M.D. - Mayo Clinic

    ... hemoglobin Evans with secondary methemoglobinemia. J Clin Apher. 2023 Dec; 38 (6):755-759 Epub 2023 Sept 04. View PubMed; Williams LA 3rd, Thiele BA, Kinard T ...

  9. Von Willebrand disease - Symptoms & causes - Mayo Clinic

    Learn more about the symptoms, causes, diagnosis and treatment of this inherited bleeding condition that keeps blood from clotting well.

  10. Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors - Mayo Clinic

    Hemoglobin ≥8.0 g/dL;; Transfusions are permitted to meet both the platelet and hemoglobin criteria. Patients must not be known to be refractory to red ...